Implication of Rituximab Infusion Reactions on Clinical Outcomes in Patients With Diffuse Large B-cell Lymphoma: A Single Institution Experience

Dilan A. Patel, Tanner M. Johanns, Kathryn Trinkaus, Nancy L. Bartlett, Nina Wagner-Johnston, Amanda F. Cashen

Research output: Contribution to journalArticle

Abstract

In a retrospective study of 229 patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy regimens, we show that patients who experienced an infusion reaction had a higher probability of survival compared with those who did not.

Original languageEnglish (US)
JournalClinical Lymphoma, Myeloma and Leukemia
DOIs
StateAccepted/In press - Jan 1 2019

Keywords

  • Complement
  • Diffuse large B-cell lymphoma
  • Immunochemotherapy
  • Infusion reaction
  • Rituximab

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Implication of Rituximab Infusion Reactions on Clinical Outcomes in Patients With Diffuse Large B-cell Lymphoma: A Single Institution Experience'. Together they form a unique fingerprint.

  • Cite this